ESLA
Estrella Immunopharma (ESLA)
$93
About Estrella Immunopharma (ESLA)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
$1.04
Daily low
$0.90
Price at open
$1.04
52 Week High
$3.15
52 Week Low
$0.78
Market cap
40.9M
Dividend yield
0.00%
Volume
33,264
Avg. volume
41,913
P/E ratio
-2.69
Estrella Immunopharma News
Details
Daily high
$1.04
Daily low
$0.90
Price at open
$1.04
52 Week High
$3.15
52 Week Low
$0.78
Market cap
40.9M
Dividend yield
0.00%
Volume
33,264
Avg. volume
41,913
P/E ratio
-2.69